These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 27461636)
21. Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer. Huang X; Yang Y; Guo Y; Cao ZL; Cui ZW; Hu TC; Gao LB Genet Mol Res; 2015 Dec; 14(4):16913-20. PubMed ID: 26681038 [TBL] [Abstract][Full Text] [Related]
22. The effect of oxoguanine glycosylase 1 rs1052133 polymorphism on colorectal cancer risk in Caucasian population. Su Y; Xu A; Zhu J Tumour Biol; 2014 Jan; 35(1):513-7. PubMed ID: 23975367 [TBL] [Abstract][Full Text] [Related]
23. The PTPN13 Y2081D (T>G) (rs989902) polymorphism is associated with an increased risk of sporadic colorectal cancer. Laczmanska I; Karpinski P; Gil J; Laczmanski L; Makowska I; Bebenek M; Ramsey D; Sasiadek MM Colorectal Dis; 2017 Jul; 19(7):O272-O278. PubMed ID: 28504867 [TBL] [Abstract][Full Text] [Related]
24. The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a meta-analysis of 32 studies. Wang J; Wang Q; Liu H; Shao N; Tan B; Zhang G; Wang K; Jia Y; Ma W; Wang N; Cheng Y Mutagenesis; 2012 Nov; 27(6):779-88. PubMed ID: 22952151 [TBL] [Abstract][Full Text] [Related]
25. Implicating the H63D polymorphism in the HFE gene in increased incidence of solid cancers: a meta-analysis. Shen LL; Gu DY; Zhao TT; Tang CJ; Xu Y; Chen JF Genet Mol Res; 2015 Oct; 14(4):13735-45. PubMed ID: 26535689 [TBL] [Abstract][Full Text] [Related]
26. Significant association between Let-7-KRAS rs712 G > T polymorphism and cancer risk in the Chinese population: a meta-analysis. Du XY; Hu YY; Xie C; Deng CY; Liu CY; Luo ZG; Niu YM; Shen M Oncotarget; 2017 Feb; 8(8):13863-13871. PubMed ID: 28099923 [TBL] [Abstract][Full Text] [Related]
27. The 811 C/T polymorphism in the 3' untranslated region of the selenoprotein 15-kDa (Sep15) gene and breast cancer in Caucasian women. Watrowski R; Castillo-Tong DC; Fabjani G; Schuster E; Fischer M; Zeillinger R Tumour Biol; 2016 Jan; 37(1):1009-15. PubMed ID: 26264612 [TBL] [Abstract][Full Text] [Related]
28. CCND1 rs9344 polymorphism is associated with the risk of hepatocellular carcinoma in Caucasian population. Wang DD; Duan WD; Zhu ZM; Tu YL; Dou CQ; Han MM; Zhang B; Zhao W; Jiang K J Cancer Res Ther; 2018 Jun; 14(Supplement):S516-S518. PubMed ID: 29970717 [TBL] [Abstract][Full Text] [Related]
29. XPA A23G polymorphism and susceptibility to cancer: a meta-analysis. Liu J; Zhang Z; Cao XL; Lei DP; Wang ZQ; Jin T; Pan XL Mol Biol Rep; 2012 Jun; 39(6):6791-9. PubMed ID: 22314912 [TBL] [Abstract][Full Text] [Related]
30. The MDM2 SNP309T>G polymorphism increases bladder cancer risk among Caucasians: a meta-analysis. Wang HG; Wu QY; Zhou H; Peng XS; Shi MJ; Li JM; Zhou YF Asian Pac J Cancer Prev; 2014; 15(13):5277-81. PubMed ID: 25040988 [TBL] [Abstract][Full Text] [Related]
31. Lack of an Association between a Polymorphism in the KRAS 3' Untranslated Region (rs61764370) and Endometriosis in a Large European Case-Control Study. D'Hooghe TM; Grechukhina O; Cho S; Fassbender A; O D; Peterse D; Weidhaas J; Taylor HS Gynecol Obstet Invest; 2019; 84(6):575-582. PubMed ID: 31185482 [TBL] [Abstract][Full Text] [Related]
32. The -137G>C polymorphism in interleukin-18 promoter region and cancer risk: evidence from a meta-analysis of 21 studies. Liang TJ; Ma H; Wang CX; Liu YR; Wang XG Tumour Biol; 2013 Dec; 34(6):3483-90. PubMed ID: 23794112 [TBL] [Abstract][Full Text] [Related]
33. A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. Chung CH; Lee JW; Slebos RJ; Howard JD; Perez J; Kang H; Fertig EJ; Considine M; Gilbert J; Murphy BA; Nallur S; Paranjape T; Jordan RC; Garcia J; Burtness B; Forastiere AA; Weidhaas JB Ann Oncol; 2014 Nov; 25(11):2230-2236. PubMed ID: 25081901 [TBL] [Abstract][Full Text] [Related]
34. Association between MCP-1 -2518A/G polymorphism and cancer risk: evidence from 19 case-control studies. Da LS; Zhang Y; Zhang S; Qian YC; Zhang Q; Jiang F; Xu L PLoS One; 2013; 8(12):e82855. PubMed ID: 24367564 [TBL] [Abstract][Full Text] [Related]
35. PLCE1 rs2274223 A>G polymorphism and cancer risk: a meta-analysis. Umar M; Upadhyay R; Mittal B Tumour Biol; 2013 Dec; 34(6):3537-44. PubMed ID: 23797815 [TBL] [Abstract][Full Text] [Related]
36. A let-7 KRAS rs712 polymorphism increases colorectal cancer risk. Pan XM; Sun RF; Li ZH; Guo XM; Zhang Z; Qin HJ; Xu GH; Gao LB Tumour Biol; 2014 Jan; 35(1):831-5. PubMed ID: 23975373 [TBL] [Abstract][Full Text] [Related]
38. Increased risk of breast cancer associated with CC genotype of Has-miR-146a Rs2910164 polymorphism in Europeans. Lian H; Wang L; Zhang J PLoS One; 2012; 7(2):e31615. PubMed ID: 22363684 [TBL] [Abstract][Full Text] [Related]
39. The association between myeloperoxidase 463G>A polymorphisms and risk of lung cancer in East-Asia population. Hou X; Gao Y; Duan Y; Wang Z; Shi L; Ma J; Xie X J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C97-100. PubMed ID: 26323935 [TBL] [Abstract][Full Text] [Related]
40. Let-7 microRNA-binding-site polymorphism in the 3'UTR of KRAS and colorectal cancer outcome: a systematic review and meta-analysis. Langevin SM; Christensen BC Cancer Med; 2014 Oct; 3(5):1385-95. PubMed ID: 24890702 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]